Marex Group’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Sell
3,807
-11,798
-76% -$1.79M ﹤0.01% 599
2025
Q4
$2.24M Buy
15,605
+12,869
+470% +$1.9M 0.01% 299
2025
Q3
$420K Buy
+2,736
New +$427K ﹤0.01% 545
2025
Q2
Sell
-2,448
Closed -$417K 863
2025
Q1
$417K Buy
2,448
+191
+8% +$32K 0.01% 378
2024
Q4
$378K Buy
2,257
+806
+56% +$137K 0.01% 407
2024
Q3
$251K Buy
+1,451
New +$246K 0.01% 421
2024
Q1
Sell
-5,676
Closed -$832K 631
2023
Q4
$832K Buy
+5,676
New +$841K 0.03% 240
2023
Q2
Sell
-4,419
Closed -$657K 288
2023
Q1
$657K Buy
4,419
+2,812
+175% +$402K 0.09% 142
2022
Q4
$244K Buy
+1,607
New +$225K 0.03% 213

Other funds holding PG

Marex Group's PG Position: Q1 2026 in Review

Marex Group reduced its Procter & Gamble (PG) stake by 76% in Q1 2026, selling an estimated $1.79M and leaving 3,807 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Marex Group first reported a position in PG in Q4 2022 and has held it in 9 quarters since. The position peaked at $2.24M in Q4 2025. 3,986 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Marex Group held 3,807 shares of Procter & Gamble worth $550K as of Q1 2026.
  • Marex Group sold 11,798 Procter & Gamble shares in Q1 2026, an estimated $1.79M.
  • Procter & Gamble made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #599 holding.
  • Marex Group first reported a position in Procter & Gamble in Q4 2022 and has held it in 9 quarters since.
  • Marex Group's Procter & Gamble position peaked at $2.24M in Q4 2025.
  • 3,986 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.